Absorption |
Blood-Brain Barrier | BBB+ | 0.9501 |
Human Intestinal Absorption | HIA+ | 0.9795 |
Caco-2 Permeability | Caco2+ | 0.6431 |
P-glycoprotein Substrate | Non-substrate | 0.7975 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9747 |
Non-inhibitor | 0.9750 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9249 |
Distribution |
Subcellular localization | Lysosome | 0.6306 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8271 |
CYP450 2D6 Substrate | Non-substrate | 0.8325 |
CYP450 3A4 Substrate | Non-substrate | 0.7629 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9050 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9167 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9611 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9461 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9736 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8835 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9674 |
Non-inhibitor | 0.9544 |
AMES Toxicity | Non AMES toxic | 0.9446 |
Carcinogens | Carcinogens | 0.7387 |
Fish Toxicity | Low FHMT | 0.6303 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6648 |
Honey Bee Toxicity | High HBT | 0.7726 |
Biodegradation | Not ready biodegradable | 0.6210 |
Acute Oral Toxicity | III | 0.6022 |
Carcinogenicity (Three-class) | Non-required | 0.5655 |